China Medical Device Classification Assistance Tool
China’s National Medical Products Administration (NMPA) classifies all medical devices into 3 risk-based classes — a decision that determines your entire registration pathway, testing burden, and timeline. Our Classification Assistance Tool helps foreign manufacturers correctly identify their device’s class in under 5 minutes, based on 40+ classification criteria and 1,000+ reference product examples. Misclassification delays market entry by 12–24 months and can cost upwards of RMB 500,000 in rework.
In China, medical devices (医疗器械, yīliáo qìxiè) are regulated under the Regulations on the Supervision and Administration of Medical Devices. The classification system follows a structured rule set that considers invasiveness, duration of contact, energy source, and clinical function. Our tool maps your device specifications against the official Classification Catalog (医疗器械分类目录, yīliáo qìxiè fēnlèi mùlù) to generate a precise class recommendation with supporting rationale.
How China’s Three-Class System Works
Class I devices (第一类医疗器械, dì yī lèi yīliáo qìxiè) are low-risk, non-invasive products such as bandages and examination gloves. These require only filing (record-keeping) with the local NMPA branch — no technical review or clinical data needed. Class II devices (第二类医疗器械, dì èr lèi yīliáo qìxiè) include moderate-risk products like diagnostic ultrasound equipment and infusion pumps. They require provincial NMPA registration with technical documentation, type testing, and generally no clinical trials if equivalence can be proven.
Class III devices (第三类医疗器械, dì sān lèi yīliáo qìxiè) cover high-risk products such as implantable pacemakers and vascular stents. These demand central NMPA registration in Beijing, full technical documentation, type testing at an NMPA-accredited lab, and often clinical trial data. The entire process for Class III typically spans 2–3 years versus 1–2 years for Class II and only 2–4 months for Class I.
| Class | Risk Level | Registration Authority | Type Testing Required | Clinical Trial Required | Typical Timeline | Estimated Cost (RMB) |
|---|---|---|---|---|---|---|
| Class I | Low | Local NMPA (filing only) | No | No | 2–4 months | 30,000–80,000 |
| Class II | Moderate | Provincial NMPA | Yes | Usually no (equivalence route available) | 1–2 years | 200,000–600,000 |
| Class III | High | Central NMPA (Beijing) | Yes | Often required | 2–3 years | 800,000–2,500,000 |
What the Classification Assistance Tool Delivers
Our tool asks 8–12 targeted questions about your device: its intended use, anatomical location, duration of patient contact, energy source (active vs. passive), sterilization method, and whether it delivers medication. Based on your inputs, the tool cross-references the official 40-category classification catalog and outputs a recommended class, the relevant classification code (e.g., 6823 for ultrasound imaging), and a list of comparable registered devices already on the Chinese market.
You also receive a downloadable summary report that includes the regulatory basis for the classification decision — useful when submitting your registration dossier or when discussing with your local agent or legal representative. The tool updates automatically whenever NMPA revises the classification catalog, which occurs approximately every 2 years.
Key Inputs Required
- Product description — name, function, materials
- Intended use statement — exact claims for Chinese labeling
- Anatomical site & contact duration — skin, blood, bone, temporary vs. permanent
- Energy source — battery-powered, mains-operated, or non-electric
- Sterilization method — ethylene oxide, gamma, autoclave, or single-use sterile
Why Correct Classification Is Non-Negotiable
A Class III device incorrectly filed as Class II will be rejected during technical review, wasting 8–14 months and all fees paid to the testing lab (typically RMB 150,000–400,000). A Class II device mistakenly treated as Class I may pass filing, but during post-market inspection — which occurs for 20% of newly registered devices within the first 2 years — NMPA can revoke the registration, issue fines up to RMB 1,000,000, and ban the importer from re-registering for 1 year.
Conversely, over-classifying a device (e.g., Class II instead of Class I) imposes unnecessary clinical trial costs and a 12–18 month delay with no regulatory benefit. Our tool prevents both extremes by applying the same decision logic NMPA reviewers use internally.
Decision Framework for Classification
If your device is non-invasive, does not contact broken skin, and is not intended for prolonged use (less than 60 minutes per session), choose the Class I pathway — filing only, no testing, fastest route to market.
If your device is invasive (e.g., surgical instruments), delivers energy or medication, or is for diagnostic imaging (ultrasound, MRI), choose the Class II pathway — provincial registration with type testing, but the clinical equivalence route is usually available.
If your device is implantable, life-supporting, or contains a medicinal substance (e.g., drug-eluting stent), choose the Class III pathway — central NMPA registration, full testing, and most likely a local clinical trial.
Getting Started with the Tool
The Classification Assistance Tool is available as part of the China Gateway 360 Medical Device Registration Package. New users receive 3 free classification queries. After that, a subscription covers unlimited queries plus quarterly updates to the classification catalog database. Each query takes 5–7 minutes to complete, and the output report is generated instantly in both English and Chinese.
We also offer a manual verification service where a regulatory specialist reviews your tool output and provides a written opinion — recommended for Class III or borderline devices. This step adds 2 business days to your timeline but reduces the risk of a classification challenge during NMPA review.
NEXT STEPS
- Run the Classification Tool now — Visit our Medical Device Classification Assistance Tool page to start your first free query. Have your product specification sheet ready.
- Review your comparator products — Read our guide on China NMPA Medical Device Registration Process to understand how classification feeds into the full registration timeline.
- Engage a regulatory agent — If the tool returns Class II or III, consult our Local Agent Requirements for Medical Device Registration article to identify a qualified Chinese legal representative.
— China Gateway 360 —
Remote China market entry support, built around execution.
